文献速递癫痫神经重症与神经感染

咪达唑仑可预防新生儿窒息的不良结局

Midazolam Prevents the Adverse Outcome of Neonatal Asphyxia.
PubMed 文献 · Ann Neurol · 2022-09-15

本研究采用非侵入性大鼠窒息模型,观察窒息后14个月内行为与认知测试及免疫组化分析。所有溶剂对照大鼠均出现惊厥并发生行为认知异常、神经炎症、神经退行性变及海马苔藓纤维出芽;窒息后立即腹腔注射咪达唑仑(1 mg/kg)可使约50%大鼠免于惊厥,并预防或减轻上述不良后果。

要点

  • 窒息后立即给予咪达唑仑(1 mg/kg 腹腔注射)可使约50%大鼠免于惊厥。
  • 咪达唑仑可预防或减轻窒息后的神经炎症、行为认知异常和神经退行性变。
  • 除丘脑神经退行性变外,惊厥似乎不参与窒息的不良结局。

核心结论

  • 咪达唑仑具有疾病修饰作用,强烈提示该药为改善新生儿窒息治疗及结局提供了有价值的选择。

研究设计与样本

  • 采用非侵入性大鼠新生儿窒息模型,窒息后14个月内进行行为与认知测试,随后进行免疫组化分析。

主要发现

  • 所有溶剂对照大鼠在窒息后均出现惊厥,并在随后数月发生行为与认知异常、灰质和白质神经炎症、海马和丘脑神经退行性变以及海马苔藓纤维出芽。
  • 窒息后立即腹腔注射咪达唑仑(1 mg/kg)使约50%大鼠免于窒息后惊厥,并预防或减轻神经炎症及窒息导致的行为、认知和神经退行性变后果。
  • 除丘脑神经退行性变外,惊厥似乎不参与窒息的不良结局。

关键数值与推荐

  • 咪达唑仑剂量为1 mg/kg,腹腔注射,于窒息后立即给药。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Birth asphyxia (BA) is the most frequent cause of neonatal death as well as central nervous system (CNS) injury. BA is often associated with neonatal seizures, which only poorly respond to anti-seizure medications and may contribute to the adverse neurodevelopmental outcome. Using a non-invasive rat model of BA, we have recently reported that the potent benzodiazepine, midazolam, prevents neonatal seizures in ~50% of rat pups. In addition to its anti-seizure effect, midazolam exerts anti-inflammatory actions, which is highly relevant for therapeutic intervention following BA. The 2 major aims of the present study were to examine (1) whether midazolam reduces the adverse outcome of BA, and (2) whether this effect is different in rats that did or did not exhibit neonatal seizures after drug treatment. METHODS: Behavioral and cognitive tests were performed over 14 months after asphyxia, followed by immunohistochemical analyses. RESULTS: All vehicle-treated rats had seizures after asphyxia and developed behavioral and cognitive abnormalities, neuroinflammation in gray and white matter, neurodegeneration in the hippocampus and thalamus, and hippocampal mossy fiber sprouting in subsequent months. Administration of midazolam (1 mg/kg i.p.) directly after asphyxia prevented post-asphyctic seizures in ~50% of the rats and resulted in the prevention or decrease of neuroinflammation and the behavioral, cognitive, and neurodegenerative consequences of asphyxia. Except for neurodegeneration in the thalamus, seizures did not seem to contribute to the adverse outcome of asphyxia. INTERPRETATION: The disease-modifying effect of midazolam identified here strongly suggests that this drug provides a valuable option for improving the treatment and outcome of BA. ANN NEUROL 2023;93:226-243.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Welzel B, Schmidt R, Johne M, et al. Midazolam Prevents the Adverse Outcome of Neonatal Asphyxia. Ann Neurol. 2022. PMID: 36054632. doi:10.1002/ana.26498

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。